ProfileGDS4132 / 211728_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 43% 36% 36% 35% 42% 42% 33% 32% 32% 34% 44% 38% 32% 38% 36% 42% 35% 32% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101110.4742
GSM201543Muscle PCOS pioglitazone 121104.4143
GSM201544Muscle PCOS pioglitazone 16192.829736
GSM201545Muscle PCOS pioglitazone 20199.363936
GSM201829Muscle PCOS pioglitazone 23194.0535
GSM201830Muscle PCOS pioglitazon 251114.79742
GSM201831Muscle PCOS pioglitazone 271108.10542
GSM201832Muscle PCOS pioglitazone 3182.051333
GSM201833Muscle PCOS pioglitazone 4175.355732
GSM201834Muscle PCOS pioglitazone 8176.920632
GSM201835Muscle PCOS after pioglitazone 10270.11434
GSM201836Muscle PCOS after pioglitazone 122104.85944
GSM201837Muscle PCOS after pioglitazone 16282.7538
GSM201838Muscle PCOS after pioglitazone 20270.744832
GSM201839Muscle PCOS after pioglitazone 23290.147338
GSM201840Muscle PCOS after pioglitazone 25287.416536
GSM201841Muscle PCOS after pioglitazone 27294.040842
GSM201842Muscle PCOS after pioglitazone 3270.867435
GSM201843Muscle PCOS after pioglitazone 4277.02232
GSM201844Muscle PCOS after pioglitazone 8298.736540